CAS Medical Systems, Inc. (CASM) Reached 12-Month High at $1.49

May 16, 2018 - By Palma Niemeyer

CAS Medical Systems, Inc. (NASDAQ:CASM) Corporate Logo

Big Money Sentiment increased to 1 in Q4 2017. It has change of 0.17, from 2017Q3’s 0.83. The ratio increased due to CAS Medical Systems, Inc. positioning: 2 sold and 3 reduced. 3 funds amassed stakes and 2 increased stakes. Investors holded 6.37 million in 2017Q3 but now own 6.42 million shares or 0.78% more.
Citadel Advisors Ltd Liability accumulated 32,680 shs. Wells Fargo And Co Mn has 227 shs. Royal Financial Bank Of Canada holds 0% of its capital in CAS Medical Systems, Inc. (NASDAQ:CASM) for 20 shs. Vanguard Grp Inc holds 0% or 531,881 shs in its capital. Guggenheim Cap Ltd Liability Co owns 12,172 shs. Td Cap Limited Liability Corporation has 38,175 shs. Rmb Capital Mngmt Lc owns 20,000 shs or 0% of their US capital. Acuta Prns Ltd Limited Liability Company accumulated 5.16M shs. New York-based Two Sigma Secs Limited Liability Com has invested 0% in CAS Medical Systems, Inc. (NASDAQ:CASM). Blackrock invested 0% in CAS Medical Systems, Inc. (NASDAQ:CASM). California Pub Employees Retirement System holds 0% of its capital in CAS Medical Systems, Inc. (NASDAQ:CASM) for 10,400 shs. Morgan Stanley has 0% invested in CAS Medical Systems, Inc. (NASDAQ:CASM). Renaissance Tech Ltd Company holds 0% or 270,000 shs in its capital. Hightower Advisors Ltd accumulated 245,489 shs or 0% of the stock. Northern holds 0% of its capital in CAS Medical Systems, Inc. (NASDAQ:CASM) for 25,101 shs.

CAS Medical Systems, Inc. registered $441,587 net activity with 2 insider purchases and 1 insider sale since January 4, 2018. On Thursday, March 15 a trade for 3,000 shs valued at $3,489 was made by Gamelin John.

Today CAS Medical Systems, Inc. (NASDAQ:CASM) with $1.49 price per share, touched yearly high with $1.62 target or 9.00 % above. It was published on May, 16 according to Barchart.com. The company has $40.87 million market cap. At our $1.62 target, the company worth will be $3.68 million more.

Ticker’s shares touched $1.49 during the last trading session after 10.37% change.CAS Medical Systems, Inc. has 631,805 shares volume, 1537.78% up from normal. CASM is downtrending and has moved 14.97% since May 16, 2017. CASM underperformed the S&P 500 by 26.52%.

On August, 14 CAS Medical Systems, Inc. (NASDAQ:CASM)’s earnings report is anticipated by WallStreet, according to RTT. Analysts forecast 22.22 % diference or $-0.07 from the $-0.09 EPS from 2017. Analysts at Wall Street see CAS Medical Systems, Inc.’s 0.00 % EPS growth compared to $-0.07 earnings per share for previous quarter.

More recent CAS Medical Systems, Inc. (NASDAQ:CASM) news were brought out by Nasdaq.com, Globenewswire.com and Seekingalpha.com. The first one has “CASMED to Report First-Quarter 2018 Financial Results and Hold Conference Call on May 10” as a title and was brought out on May 03, 2018. The next is “FDA Clears CASMED’s FORE-SIGHT Tissue Oximetry OEM Module” on May 16, 2018. And last was brought out on May 12, 2018, called “CAS Medical Systems’ (CASM) CEO Tom Patton on Q1 2018 Results – Earnings Call Transcript”.

CAS Medical Systems, Inc., a non-invasive cerebral oximetry technology company, develops, makes, and markets non-invasive patient monitoring products worldwide.The company has $40.87 million market cap. The Company's FORE-SIGHT® Absolute Cerebral Oximeter provides non-invasive and continuous measurement of absolute cerebral tissue oxygenation in the brain for patients during critical care.Last it reported negative earnings. The firm provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories.

CAS Medical Systems, Inc. (NASDAQ:CASM) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.